Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 9 - Drugs for disorders of the cardiovascular system
Patents for A61P 9 - Drugs for disorders of the cardiovascular system (159,484)
03/2007
03/22/2007WO2006129237A3 Novel piperidine carboxylic acid amide derivatives
03/22/2007WO2006110887A3 Use of glp-1, exendin and agonists thereof to delay or prevent cardiac remodeling
03/22/2007WO2006086562A3 Phenylazetidinone derivatives
03/22/2007WO2006078421A3 Methods of increasing cerebral blood flow
03/22/2007WO2006060122A3 Cardiotonic compounds with inhibitory activity against beta-adrenergic receptors and phosphodiesterase
03/22/2007WO2006050585A3 Modulation of nitric oxide synthases by betaines
03/22/2007US20070067861 Cloning pigs using donor nuclei from differentiated cells
03/22/2007US20070066823 CCR9 inhibitors and methods of use thereof
03/22/2007US20070066633 Angiogenesis inhibitor; anticancer agents; antiarthritic agents; psoriasis
03/22/2007US20070066618 Use of EP4 Receptor Ligands in the Treatment of IL-6 Involved Diseases
03/22/2007US20070066585 Aryl phenylheterocyclyl sulfide derivatives and their use as cell adhesion-inhibiting anti-inflammatory and immune-suppressive agents
03/22/2007US20070066576 Compounds which modulate 2OG (2-oxoglutarate) dependent oxygenases, in particular prolyl hydroxylases; may be useful as modulators of HIF (hypoxia inducible factor) alpha (HIF- alpha ) prolyl hydroxylase; for example, analogues of 2-oxoglutarate, N-phenoxy-acetyl-(L)-alanine-hydroxamide
03/22/2007US20070066539 Base-substituted benzylamine analogs for use as coagulation factor xa inhibitors, the production and use thereof
03/22/2007US20070066535 Novel amino acid sequences are within the carboxy termini of fibrinogen; useful for cell culture and cell separation
03/22/2007US20070066524 for inhibiting apoptosis in mammalian cells; zinc finger domains; consensus sequences; genetic engineering; for treating AIDS, alzheimer's disease, parkinson's disease, amyotrophic lateral sclerosis (ALS), retinitis pigmentosa, autoimmune diseases
03/22/2007US20070066523 Chemokine analogs for the treatment of human diseases
03/22/2007US20070066513 photosensitizers used in the photodynamic therapy of microbial infections, tumors, pre-cancerous and proliferative pathologies and/or in the diagnosis, as well as for blood and blood derivatives sterilization
03/22/2007US20070065941 Nerve cells obtained by the method of the present invention have the flexibility to differentiate into a variety of types of neurons in vivo preferably without the need for application of growth factors; Embryonic Stem (ES) cells
03/22/2007US20070065938 Perivascular mesenchymal precursor cells
03/22/2007US20070065921 Methods and products related to producing low molecular weight heparin
03/22/2007US20070065868 IL-17 receptor like molecules and uses thereof
03/22/2007US20070065517 Modafinil Pharmaceutical Compositions
03/22/2007US20070065493 External patch containing estrogen and/or progestogen
03/22/2007US20070065485 Therapeutic delivery of carbon monoxide
03/22/2007US20070065453 Transferrin-binding proteins from neisseria gonorrhoeae and neisseria meningitidis
03/22/2007US20070065380 provitamin C is prepared from Lycium fruit extract; decomposed in the body to produce vitamin C; improved stability in the body and prolonged life in the body; bioavailability; vitamin C-fortified food; apply to skin protecting from ultraviolet damage, wrinkles and aging
03/22/2007DE102005042877A1 Use of PDE1A polypeptides, or nucleic acid, for identifying their specific inhibitors, which are useful for treatment and prevention of cardiac insufficiency
03/22/2007CA2622725A1 5-oxo-5,8-dihydro-pyrido-pyrimidines as inhibitors of c-fms kinase
03/22/2007CA2622605A1 Heterocycle compound, and production process and application thereof
03/22/2007CA2622375A1 Alcanoic acid amides substituted by saturated o-heterocycles
03/22/2007CA2622082A1 5-amino-4-hydroxy-7- (imidazo [1,2-a] pyridin-6- ylmethyl)-8-methyl-nonamide derivatives and related compounds as renin inhibitors for the treatment of hypertension
03/22/2007CA2621292A1 1-2-dihydroquinoline derivative having glucocorticoid receptor binding actvity
03/22/2007CA2620296A1 Combination drug containing probucol and a tetrazolylalkoxy-dihydrocarbostyril derivative with superoxide supressant effects
03/21/2007EP1764370A2 Methods of treatment of inflammatory diseases using specific binding agents of human angiopoietin - 2
03/21/2007EP1764366A2 Thrombin receptor antagonists
03/21/2007EP1764362A1 Biaryl derivatives
03/21/2007EP1764358A2 Cyclic amides as vanilloid receptor ligands and their use in treatments of inflammatory and neuropathic pain
03/21/2007EP1764106A2 Use of insulin-like growth factor I for the inhibition of ischemic injury involving the liver
03/21/2007EP1764075A1 Tissue factor production inhibitor
03/21/2007EP1763525A2 Stable micronized candesartan cilexetil and methods for preparing thereof
03/21/2007EP1763516A2 Substituted tetrahydroisochinolines used in the form of mmp inhibitors, method for the production and use thereof in the form of drags
03/21/2007EP1763345A2 Kinase inhibitors for treating cancers
03/21/2007EP1763343A2 Calcium trifluoroacetate for preparing antiangiogenetic medicaments
03/21/2007EP1763338A2 Oral sustained release formulation of tedisamil with gastric retention properties
03/21/2007EP1487821B1 Benzodiazepine-substituted piperidines for utilization in the treatment of cardiovascular diseases
03/21/2007EP1453801B1 Substituted 2-amino-cycloalkanecarboxamides and their use as cysteine protease inhibitors
03/21/2007EP1451177B1 Substituted 2-pyrrolidine-2-yl-1h-indole derivatives for the treatment of migraine
03/21/2007EP1439176B1 Pyrimidone compounds and pharmaceutical compositions containing the same
03/21/2007EP1397127B1 Solid pharmaceutucal formulations comprising modafinil
03/21/2007EP1303305B1 Epoxy-steroidal aldosterone antagonist and calcium channel blocker combination therapy for treatment of congestive heart failure
03/21/2007EP1231982B1 Use of phthalazine derivatives for the treatment of neurodegenerative diseases
03/21/2007EP1216024B1 Formulation for menopausal women
03/21/2007CN1934122A Fused heterocycle derivative, medicinal composition containing the same, and medicinal use thereof
03/21/2007CN1934116A Tricyclic benzopyran compound as anti-arrhythmic agents
03/21/2007CN1934103A Fused heterocycle derivative, medicinal composition containing the same, and medicinal use thereof
03/21/2007CN1934100A Substituted quinazoline or pyridopyrimidine derivative
03/21/2007CN1934094A Diaryl-substituted five-membered heterocycle derivative
03/21/2007CN1934083A 2,7-substituted 5-amino-4-hydroxy-8-(1h-indol-5-yl)-octan amide derivatives as renin inhibitors for the treatment of hypertension
03/21/2007CN1934082A Organic compounds
03/21/2007CN1934073A Novel crystal of triterpene derivative
03/21/2007CN1933848A Y2 selective receptor agonists for therapeutic interventions
03/21/2007CN1933827A Use of methylene amide derivatives in cardiovascular disorders
03/21/2007CN1933823A Use of renin inhibitors in therapy
03/21/2007CN1931868A Figwort total phenyl glycoside and its prepn process and application
03/21/2007CN1931859A New fused imidazole derivative
03/21/2007CN1931851A Compound 2,3,4,6,8-pentamethoxyl-dibenzofuran and its use
03/21/2007CN1931362A Application of human urokinase-type peptidase in preparing medicine for treating diabetes combined cerebral infraction
03/21/2007CN1931359A Orally administered peptides to ameliorate atherosclerosis
03/21/2007CN1931358A Orally administered peptides to ameliorate atherosclerosis
03/21/2007CN1931354A Arrhythmia treating Chinese medicine prepn and its prepn process
03/21/2007CN1931353A Curcuma extract and its prepn process, medicine composition and use
03/21/2007CN1931348A Hyperlipemia treating Chinese medicine prepn
03/21/2007CN1931343A Quality standard and inspection method for coronary heart disease treating medicine tablet of seven ingredients
03/21/2007CN1931326A Apoplexy treating capsule
03/21/2007CN1931323A Mailuoning soft capsule and its prepn process
03/21/2007CN1931322A Anal fistula treating Chinese medicine
03/21/2007CN1931319A Medicine for treating female climacteric syndrome and endocrine disorder and its prepn process
03/21/2007CN1931315A Medicine for treating thromboangiitis obliterans of lower limb and its prepn process
03/21/2007CN1931296A Pinellia tuber extract and its prepn process, medicine composition and use
03/21/2007CN1931294A Chinese medicine composition for treating ischemic apoplexy and its prepn process
03/21/2007CN1931293A Oil-in-water type nanometer grassleaved sweetflag oil emulsion oral liquid and its prepn process
03/21/2007CN1931287A Chinese medicine composition for treating piles and its prepn process
03/21/2007CN1931281A Prepn process of capsule for lowering blood lipid, blood sugar and blood pressure
03/21/2007CN1931274A Pile treating suppository prepared with longan stone and its prepn process
03/21/2007CN1931271A Evodia extract and its prepn process, medicine composition and use
03/21/2007CN1931261A Blood pressure and blood lipid lowering capsule and its prepn process
03/21/2007CN1931248A Medicine composition and its prepn process
03/21/2007CN1931242A Chinese medicine composition for treating cardio palmus and its prepn process
03/21/2007CN1931236A Medicine composition of red sage and rhodiola root
03/21/2007CN1931235A Medicine composition for treating cardiac and cerebral vascular diseases and its prepn process
03/21/2007CN1931234A Medicine composition of red sage and puerarin
03/21/2007CN1931233A Medicine composition of red sage and epimedium for treating cardiac and cerebral vascular diseases
03/21/2007CN1931232A Oil-in-water nanometer perilla seed oil emulsion oral liquid and its prepn process
03/21/2007CN1931225A Use of flavescent sophora root in preparing medicine for preventing and treating angiostenosis
03/21/2007CN1931218A Medicine composition of ligustrazine and rhodiola root
03/21/2007CN1931217A Medicine composition of gingko leaf and rhodiola root
03/21/2007CN1931216A Medicine composition of safflower and rhodiola root
03/21/2007CN1931214A Medicine composition of rhodiola root and puerarin
03/21/2007CN1931206A Compound oral prepn of muskone and total arasaponin and its application
03/21/2007CN1931205A Kindir leaf total flavone extract and its prepn and application
1 ... 634 635 636 637 638 639 640 641 642 643 644 645 646 647 648 649 650 651 652 653 654 ... 1595